Speaker illustration

Mr Virginnio Proost

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

The eligibility of patients with an inherited cardiac disease for therapy with a subcutaneous implantable cardioverter-defibrillator.

Event: ESC Congress 2022

Topic: Device Treatment

Session: Device treatment of arrhythmias

Thumbnail

This platform is supported by

logo Novo Nordisk